Fixed-Duration Epcoritamab in Combination with Bendamustine + Rituximab for First-Line Treatment of Follicular Lymphoma: Initial Results from Epcore NHL-2 Arm 3
Year: 2024
Type: conference-abstract
Source: Blood
Institutions: Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, Candiolo Cancer Institute, University Medical Center Groningen, University of Groningen, Ghent University Hospital, AZ Sint-Jan, AbbVie (United States), Genmab (United States), University of Manchester, The Christie NHS Foundation Trust, Cancer Research UK Manchester Centre
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405042213